Goldberg Mark Alan
Insider CIK 1532475 · GLYC Director · LIFE Director · BPMC Director · BOLD Director · IMGN Director · IDRA Director · GEVA SVP,Medical&Regulatory Affairs
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 7,500 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 10,909 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,875 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,500 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,500 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,570 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer | 2025-07-17 | 2025-07-21 | 3,902 | — | $0 | 18,254 | SEC↗ |
| BPMC Blueprint Medicines Corp | U Tender | 2025-07-17 | 2025-07-21 | 18,254 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2025-06-18 | 2025-06-24 | 3,902 | $128.12 | $499.9K | 22,156 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2024-06-12 | 2024-06-14 | 4,570 | — | $0 | 4,570 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2024-06-12 | 2024-06-14 | 2,242 | — | $0 | 18,254 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2024-05-01 | 2024-05-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award | 2024-03-29 | 2024-04-02 | 4,584 | $3.00 | $13.8K | 24,828 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 18,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 18,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 5,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 50,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 19,597 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 160,350 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 13,090 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer | 2024-02-12 | 2024-02-12 | 60,720 | — | $0 | 0 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award | 2023-12-29 | 2024-01-02 | 5,827 | $2.36 | $13.8K | 20,244 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award | 2023-12-29 | 2024-01-03 | 569 | $29.65 | $16.9K | 60,720 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise deriv | 2023-10-30 | 2023-11-01 | 10,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise | 2023-10-30 | 2023-11-01 | 10,000 | $14.70 | $147.0K | 70,151 | SEC↗ |
| IMGN ImmunoGen, Inc. | M Exercise | 2023-10-30 | 2023-11-01 | 10,000 | $15.08 | $150.8K | 60,151 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award | 2023-09-30 | 2023-10-03 | 9,167 | $1.50 | $13.8K | 14,417 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award | 2023-09-29 | 2023-10-02 | 1,063 | $15.87 | $16.9K | 60,151 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award | 2023-06-30 | 2023-07-05 | 894 | $18.87 | $16.9K | 59,088 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2023-06-21 | 2023-06-23 | 5,300 | — | $0 | 5,300 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2023-06-21 | 2023-06-23 | 2,600 | — | $0 | 16,012 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 19,597 | — | $0 | 19,597 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 13,090 | — | $0 | 13,090 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2023-05-19 | 2023-05-22 | 35,000 | — | $0 | 35,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award | 2023-03-31 | 2023-04-04 | 4,394 | $3.84 | $16.9K | 58,194 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-12-30 | 2023-01-04 | 3,402 | — | $0 | 160,350 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-09-30 | 2022-10-04 | 3,530 | — | $0 | 156,948 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-06-30 | 2022-07-05 | 3,750 | — | $0 | 153,418 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2022-06-23 | 2022-06-27 | 26,000 | — | $0 | 26,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2022-06-21 | 2022-06-30 | 5,300 | — | $0 | 5,300 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2022-06-21 | 2022-06-30 | 2,600 | — | $0 | 13,412 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 44,000 | $3.37 | $148.3K | 44,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 15,000 | — | $0 | 149,668 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2022-05-18 | 2022-05-20 | 21,000 | — | $0 | 21,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-03-31 | 2022-04-04 | 3,151 | — | $0 | 134,274 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-03-31 | 2022-04-20 | 3,545 | — | $0 | 134,668 | SEC↗ |
| BPMC Blueprint Medicines Corp | P Buy | 2022-03-03 | 2022-03-07 | 5,000 | $59.98 | $299.9K | 10,812 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2021-12-31 | 2022-01-04 | 1,819 | — | $0 | 131,123 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2021-09-30 | 2021-10-01 | 2,380 | — | $0 | 129,304 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2021-06-30 | 2021-07-02 | 2,048 | — | $0 | 126,924 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 15,000 | — | $0 | 124,876 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 44,000 | $6.77 | $297.9K | 44,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2021-06-08 | 2021-06-10 | 26,000 | — | $0 | 26,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2021-06-02 | 2021-06-04 | 4,500 | — | $0 | 4,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2021-06-02 | 2021-06-04 | 2,250 | — | $0 | 5,812 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2021-05-18 | 2021-05-27 | 10,500 | — | $0 | 10,500 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award | 2021-05-18 | 2021-05-27 | 5,250 | — | $0 | 5,250 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award | 2021-04-01 | 2021-04-05 | 10,511 | $1.32 | $13.9K | 48,610 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2021-03-31 | 2021-04-02 | 1,666 | — | $0 | 109,876 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award | 2021-01-04 | 2021-01-06 | 3,452 | $4.02 | $13.9K | 38,099 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2020-12-31 | 2021-01-04 | 2,093 | — | $0 | 108,210 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-12-24 | 2020-12-28 | 5,455 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-12-24 | 2020-12-28 | 5,455 | $125.00 | $681.9K | 3,562 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-12-24 | 2020-12-28 | 5,455 | $28.15 | $153.6K | 9,017 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-12-18 | 2020-12-22 | 5,454 | — | $0 | 5,455 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-12-18 | 2020-12-22 | 5,454 | $120.00 | $654.5K | 3,562 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-12-18 | 2020-12-22 | 5,454 | $28.15 | $153.5K | 9,016 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-12-11 | 2020-12-15 | 5,455 | — | $0 | 10,909 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-12-11 | 2020-12-15 | 5,455 | $115.00 | $627.3K | 3,562 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-12-11 | 2020-12-15 | 5,455 | $28.15 | $153.6K | 9,017 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-12-01 | 2020-12-03 | 5,454 | — | $0 | 16,364 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-12-01 | 2020-12-03 | 5,454 | $110.00 | $599.9K | 3,562 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-12-01 | 2020-12-03 | 5,454 | $28.15 | $153.5K | 9,016 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-10-19 | 2020-10-21 | 5,455 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-10-19 | 2020-10-21 | 5,455 | $105.00 | $572.8K | 3,562 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-10-19 | 2020-10-21 | 5,455 | $19.53 | $106.5K | 9,017 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-10-07 | 2020-10-09 | 5,454 | — | $0 | 5,455 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-10-07 | 2020-10-09 | 5,454 | $100.00 | $545.4K | 3,562 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-10-07 | 2020-10-09 | 5,454 | $19.53 | $106.5K | 9,016 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award | 2020-10-01 | 2020-10-05 | 6,166 | $2.25 | $13.9K | 34,647 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2020-09-30 | 2020-10-01 | 3,750 | — | $0 | 106,117 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award | 2020-07-01 | 2020-07-02 | 7,751 | $1.79 | $13.9K | 28,481 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2020-06-30 | 2020-07-02 | 2,934 | — | $0 | 102,367 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2020-06-24 | 2020-06-26 | 4,500 | — | $0 | 4,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2020-06-24 | 2020-06-26 | 2,250 | — | $0 | 3,562 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-06-19 | 2020-06-23 | 1,312 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-06-19 | 2020-06-23 | 1,312 | — | $0 | 1,312 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2020-06-17 | 2020-06-18 | 17,000 | — | $0 | 99,433 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2020-06-17 | 2020-06-18 | 50,000 | $4.56 | $228.0K | 50,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2020-05-22 | 2020-05-27 | 21,000 | — | $0 | 21,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2020-05-12 | 2020-05-19 | 11,500 | — | $0 | 11,500 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award | 2020-04-01 | 2020-04-03 | 10,730 | $1.28 | $13.7K | 20,730 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2020-03-31 | 2020-04-02 | 3,958 | — | $0 | 82,433 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 18,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 16,200 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 10,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 4,500 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | U Tender | 2020-01-15 | 2020-01-15 | 1,500 | $60.00 | $90.0K | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2019-12-31 | 2020-01-02 | 2,641 | — | $0 | 78,475 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2019-09-30 | 2019-10-02 | 5,578 | — | $0 | 75,834 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2019-06-30 | 2019-07-01 | 6,221 | — | $0 | 70,256 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2019-06-20 | 2019-06-24 | 4,000 | — | $0 | 64,035 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2019-06-20 | 2019-06-24 | 18,000 | $2.10 | $37.8K | 18,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2019-06-19 | 2019-06-20 | 1,312 | — | $0 | 1,312 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2019-06-19 | 2019-06-20 | 4,875 | — | $0 | 4,875 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2019-06-04 | 2019-06-06 | 11,500 | — | $0 | 11,500 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2019-05-17 | 2019-05-21 | 21,000 | — | $0 | 21,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2019-03-31 | 2019-04-01 | 4,981 | — | $0 | 60,035 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2019-02-06 | 2019-02-08 | 16,200 | — | $0 | 16,200 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2018-12-31 | 2019-01-02 | 2,812 | — | $0 | 55,054 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | P Buy | 2018-12-19 | 2018-12-20 | 10,000 | $3.19 | $31.9K | 10,000 | SEC↗ |
| IMGN IMMUNOGEN INC | P Buy | 2018-11-06 | 2018-11-07 | 30,000 | $5.76 | $172.8K | 53,800 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2018-09-30 | 2018-10-01 | 1,425 | — | $0 | 52,242 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2018-06-30 | 2018-07-02 | 1,227 | — | $0 | 50,817 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2018-06-21 | 2018-06-25 | 7,500 | — | $0 | 51,136 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2018-06-20 | 2018-06-22 | 4,000 | — | $0 | 49,590 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2018-06-20 | 2018-06-22 | 18,000 | $11.21 | $201.8K | 18,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2018-06-20 | 2018-06-22 | 50,000 | $1.53 | $76.5K | 50,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2018-06-08 | 2018-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2018-05-18 | 2018-05-21 | 11,000 | — | $0 | 11,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2018-03-31 | 2018-04-02 | 1,118 | — | $0 | 45,590 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2018-01-18 | 2018-01-19 | 4,500 | — | $0 | 4,500 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2018-01-01 | 2018-01-19 | 18,000 | — | $0 | 18,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2017-12-31 | 2018-01-03 | 1,833 | — | $0 | 44,472 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2017-09-30 | 2017-10-03 | 1,535 | — | $0 | 42,639 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2017-09-30 | 2017-01-03 | 5,759 | — | $0 | 33,416 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2017-06-30 | 2017-07-03 | 1,652 | — | $0 | 41,104 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2017-06-21 | 2017-06-23 | 10,909 | — | $0 | 43,636 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2017-06-13 | 2017-06-15 | 10,000 | $4.64 | $46.4K | 10,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2017-06-13 | 2017-06-15 | 3,000 | — | $0 | 39,452 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2017-06-07 | 2017-06-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2017-05-25 | 2017-05-30 | 11,000 | — | $0 | 11,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2017-05-09 | 2017-05-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2017-03-31 | 2017-04-04 | 3,036 | — | $0 | 36,452 | SEC↗ |
| IMGN IMMUNOGEN INC | P Buy | 2016-12-15 | 2016-12-15 | 20,000 | $1.80 | $36.0K | 23,800 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2016-12-09 | 2016-12-13 | 5,000 | $1.84 | $9.2K | 5,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2016-12-09 | 2016-12-13 | 1,500 | — | $0 | 27,657 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2016-09-30 | 2016-10-03 | 4,384 | — | $0 | 26,157 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2016-06-30 | 2016-07-06 | 3,814 | — | $0 | 21,773 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2016-06-23 | 2016-06-27 | 10,909 | — | $0 | 32,727 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2016-06-13 | 2016-06-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2016-05-24 | 2016-05-26 | 18,000 | — | $0 | 18,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2016-05-17 | 2016-05-19 | 11,000 | — | $0 | 11,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2016-03-31 | 2016-04-04 | 1,379 | — | $0 | 17,959 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2016-03-04 | 2016-03-07 | 10,397 | $4.77 | $49.6K | 11,497 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2016-01-27 | 2016-01-29 | 19,428 | — | $0 | 19,428 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2015-11-10 | 2015-11-12 | 10,000 | $13.07 | $130.7K | 10,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2015-11-10 | 2015-11-12 | 3,000 | — | $0 | 16,580 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2015-07-15 | 2015-08-11 | 11,000 | — | $0 | 11,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2015-07-08 | 2015-07-10 | 6,286 | — | $0 | 6,286 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2015-06-08 | 2015-06-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2014-11-11 | 2014-11-12 | 10,000 | $10.10 | $101.0K | 10,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2014-11-11 | 2014-11-12 | 3,000 | — | $0 | 13,580 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-09-19 | 2014-09-19 | 790 | — | $0 | 34,697 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-09-19 | 2014-09-19 | 790 | $65.24 | $51.5K | 562 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-09-19 | 2014-09-19 | 790 | $8.73 | $6.9K | 1,352 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-09-17 | 2014-09-18 | 4,200 | — | $0 | 35,487 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-09-17 | 2014-09-18 | 4,200 | $8.73 | $36.7K | 4,762 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-09-17 | 2014-09-18 | 4,200 | $65.06 | $273.3K | 562 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-09-16 | 2014-09-18 | 9,379 | — | $0 | 39,687 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-09-16 | 2014-09-18 | 9,379 | $65.01 | $609.7K | 562 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-09-16 | 2014-09-18 | 9,379 | $8.73 | $81.9K | 9,941 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2014-07-08 | 2014-07-10 | 15,401 | — | $0 | 15,401 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2014-06-30 | 2014-07-02 | 103 | $54.89 | $5.7K | 562 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-06-11 | 2014-06-12 | 1,926 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-06-11 | 2014-06-12 | 18,637 | — | $0 | 49,066 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-06-11 | 2014-06-12 | 1,034 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-06-11 | 2014-06-12 | 1,034 | $0.95 | $982 | 22,056 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-06-11 | 2014-06-12 | 1,926 | $0.95 | $1.8K | 2,385 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-06-11 | 2014-06-12 | 18,637 | $8.73 | $162.7K | 21,022 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2014-06-11 | 2014-06-12 | 21,597 | $80.00 | $1.73M | 459 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2014-06-09 | 2014-06-11 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2014-06-04 | 2014-06-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2014-03-17 | 2014-03-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| IDRA IDERA PHARMACEUTICALS, INC | A Award deriv | 2014-01-07 | 2014-01-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2013-12-31 | 2014-01-02 | 192 | $36.30 | $7.0K | 459 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-12-03 | 2013-12-04 | 413 | $61.02 | $25.2K | 267 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-12-03 | 2013-12-04 | 6,587 | $60.49 | $398.4K | 680 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-12-02 | 2013-12-04 | 7,000 | — | $0 | 67,703 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-12-02 | 2013-12-04 | 7,000 | $8.73 | $61.1K | 7,267 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2013-11-12 | 2013-11-13 | 3,000 | — | $0 | 3,000 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2013-11-12 | 2013-11-13 | 10,000 | $14.70 | $147.0K | 10,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-11-01 | 2013-11-04 | 7,000 | — | $0 | 74,703 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-11-01 | 2013-11-04 | 100 | $51.04 | $5.1K | 267 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-11-01 | 2013-11-04 | 3,205 | $50.34 | $161.3K | 367 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-11-01 | 2013-11-04 | 3,695 | $49.61 | $183.3K | 3,572 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-11-01 | 2013-11-04 | 7,000 | $8.73 | $61.1K | 7,267 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-10-01 | 2013-10-03 | 7,000 | — | $0 | 81,703 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-10-01 | 2013-10-03 | 7,000 | $8.73 | $61.1K | 7,267 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-10-01 | 2013-10-03 | 3,230 | $63.97 | $206.6K | 4,037 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-10-01 | 2013-10-03 | 3,770 | $64.61 | $243.6K | 267 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2013-06-28 | 2013-07-01 | 267 | $35.68 | $9.5K | 267 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-06-06 | 2013-06-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-04-01 | 2013-04-03 | 3,091 | — | $0 | 1,034 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-04-01 | 2013-04-03 | 1,325 | — | $0 | 1,926 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-04-01 | 2013-04-03 | 1,325 | $0.95 | $1.3K | 1,325 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-04-01 | 2013-04-03 | 619 | $54.92 | $34.0K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-04-01 | 2013-04-03 | 3,797 | $54.21 | $205.8K | 619 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-04-01 | 2013-04-03 | 3,091 | $0.95 | $2.9K | 4,416 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-03-01 | 2013-03-06 | 4,417 | — | $0 | 3,251 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-03-01 | 2013-03-06 | 2,704 | $50.39 | $136.3K | 1,713 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-03-01 | 2013-03-06 | 4,417 | $0.95 | $4.2K | 4,417 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-03-01 | 2013-03-06 | 1,713 | $51.35 | $88.0K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-02-01 | 2013-02-05 | 4,417 | — | $0 | 7,668 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-02-01 | 2013-02-05 | 1,757 | $47.33 | $83.2K | 2,660 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-02-01 | 2013-02-05 | 2,660 | $48.02 | $127.7K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-02-01 | 2013-02-05 | 4,417 | $0.95 | $4.2K | 4,417 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2013-01-02 | 2013-01-04 | 4,417 | — | $0 | 12,085 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2013-01-02 | 2013-01-04 | 4,417 | $0.95 | $4.2K | 4,417 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | S Sale | 2013-01-02 | 2013-01-04 | 4,417 | $47.52 | $209.9K | 0 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2012-11-13 | 2012-11-15 | 2,626 | — | $0 | 2,626 | SEC↗ |
| IMGN IMMUNOGEN INC | A Award deriv | 2012-11-13 | 2012-11-15 | 4,645 | $11.42 | $53.0K | 4,645 | SEC↗ |
| IMGN IMMUNOGEN INC | P Buy | 2012-11-08 | 2012-11-09 | 3,000 | $11.27 | $33.8K | 3,800 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2012-06-27 | 2012-06-29 | 45,000 | — | $0 | 45,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2011-12-20 | 2012-01-11 | 15,000 | — | $0 | 15,000 | SEC↗ |